Novartis AG vs Atlassian Corporation PLC — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Atlassian Corporation PLC trades at $90.93 (market cap $23.67B). The key difference: Novartis AG is far larger — about 12.3× Atlassian Corporation PLC's market cap, and Novartis AG pays a 3.17% dividend while Atlassian Corporation PLC pays none. Which is the better fit depends on your goals.
| NVS | TEAM | |
|---|---|---|
Market Cap | $290.25B | $23.67B |
Sector | Health | Technology |
52-Week High | $168.62 | $203.00 |
52-Week Low | $113.50 | $57.15 |
Enterprise Value | $330.27B | $23.78B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →